Skip to main content
. 2019 Jun 15;8(5):654–662. doi: 10.1039/c9tx00052f

Table 3. Effect of doxorubicin and ZnO NPs on testicular oxidative stress biomarkers.

Groups GSH (μmol g–1 wet tissue) Catalase (unit g–1 wet tissue) MDA (nmol g–1 wet tissue)
G1 (Control) 10.49 ± 0.30b 7.21 ± 0.18a 4.88 ± 0.2b
G2 (ZnO NPs) 16.89 ± 0.41a 7.17 ± 0.17a 4.79 ± 0.16b
G3 (Doxorubicin) 6.59 ± 0.18c 3.23 ± 0.26c 12.20 ± 0.38a
G4 (Doxorubicin + ZnO NPs) 9.83 ± 0.36b 5.41 ± 0.30b 4.62 ± 0.55b